Reuters logo
BRIEF-Athersys subsidiary and leading animal health company enter into research and option agreement for cell therapy
January 18, 2017 / 11:12 AM / a year ago

BRIEF-Athersys subsidiary and leading animal health company enter into research and option agreement for cell therapy

Jan 18 (Reuters) - Athersys Inc

* Athersys subsidiary and leading animal health company enter into research and option agreement for cell therapy

* Athersys says under terms of agreement, Regenesys will receive an initial payment in exchange for an exclusive period to evaluate cell therapy technology

* Athersys Inc says additional details were not disclosed for the research and option agreement Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below